Skip to main content
Paying the price to rid the world of tuberculosis
Global Cause
health, wealth and wellbeing of our world
Climate Action
Antimicrobial Resistance
Infectious Diseases
World Food Day
More
About us
Global Resilience
World Oceans Day
Malaria
Women and Girls
Circular Economy
Refugees & Migration
Clinical Trials
Vaccines and Immunisation
World Food Day & Sustainable Packaging
Farming
Water
Malaria & NTDs
Neglected Tropical Diseases
HIV AIDS
Maternal health
Wildlife
About us
Body Empowerment
Climate Change
Ending TB
Labour Exploitation
Make a difference
Plant-Based Alternatives
Plastic
Pride
Client survey
About us
Global Resilience
World Oceans Day
Malaria
Women and Girls
Circular Economy
Refugees & Migration
Clinical Trials
Vaccines and Immunisation
World Food Day & Sustainable Packaging
Farming
Water
Malaria & NTDs
Neglected Tropical Diseases
HIV AIDS
Maternal health
Wildlife
About us
Body Empowerment
Climate Change
Ending TB
Labour Exploitation
Make a difference
Plant-Based Alternatives
Plastic
Pride
Client survey
AMR & Infectious Diseases 2024
Get to know the carbapenem-resistant superbugs brewing in hospital wastewater
AMR & Infectious Diseases 2024
Making ‘Zero Malaria’ possible with science and innovation
Sponsored
Paying the price to rid the world of tuberculosis
Sponsored
Why polymerase chain reaction diagnostics are key to fighting AMR
Sponsored
Collaborative science: key aspect to successful vaccine development
Sponsored
Controlled human infection models: accelerating tropical disease solutions
Sponsored
Mairo’s vital role in defeating severe malaria as a children’s health nurse
Mairo is the matron of an emergency paediatric unit at a hospital in Nigeria. She is part of a team caring for seriously ill children experiencing severe malaria. Caregivers anxiously wait by bedsides, hoping treatments will work and their loved ones make a full recovery. Severe malaria is a medical emergency resulting from delayed treatment … Continued
Sponsored
Why ‘doing just enough’ to combat malaria is a deadly strategy
Sponsored
History shows value of partnership to tackle health challenges
Sponsored
Customised support for major vaccine manufacturers
Infectious Diseases Q1 2024
The invisible threat: how common foodborne pathogens challenge public health
Sponsored
The power of the perfect storm: gender, malaria and the climate crisis
Sponsored
Improving patients’ medical course and reducing AMR with NGS and digital pathogen detection
Digital pathogen detection and NGS technology can quickly and accurately pinpoint the cause of infection, so patients can quickly receive more targeted and effective therapies. “Microbiological diagnostics in medicine are complex and diverse,” explains Dr med. Klaus Rensing, MBA, VP Medical Affairs at Noscendo, a provider of software-based pathogen identification technology. “Meaning, pathogens that cause … Continued
Infectious Diseases Q1 2024
Redefining TB treatment: the promise of shorter, simpler and universal regimens
Sponsored
Success in self-testing as 86% of people living with HIV globally now know their status
AMR & Infectious Diseases 2024
RSV immunisations prevent deaths and protect health systems
Sponsored
AMR in LMICs: moving evidence into action
Infectious Diseases Q1 2024
Link between fatal disease noma and extreme poverty
Infectious Diseases Q1 2024
Change needed to break the chain of tuberculosis
End tuberculosis in high-burden countries. Adapt and implement evidence-based interventions to stop the spread of this deadly, but curable, disease. The incidence of tuberculosis (TB) in countries with a high burden of this airborne disease is falling at a glacial pace. In 2022, 10.6 million people fell ill with TB and 1.3 million died — … Continued
Sponsored
Transdisciplinary partnerships for disease elimination and global health
Sponsored
Fighting back against drug resistance in malaria
Sponsored
Predicting the unpredictable: How to prepare for a pandemic
Infectious Diseases Q1 2023
Tuberculosis is still on the rise in low to middle-income countries
Infectious Diseases Q1 2023
Why we won’t be able to ‘warp speed’ our way through antibiotics